Rigel Pharmaceuticals
Stock Forecast, Prediction & Price Target
Rigel Pharmaceuticals Financial Estimates
Rigel Pharmaceuticals Revenue Estimates
Rigel Pharmaceuticals EBITDA Estimates
Rigel Pharmaceuticals Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $149.23M N/A | $120.24M -19.42% | $116.88M -2.79% | Avg: $191.50M Low: $167.07M High: $207.73M avg. 63.84% | Avg: $226.02M Low: $194.82M High: $247.55M avg. 18.02% | Avg: $240.70M Low: $207.47M High: $263.63M avg. 6.49% | Avg: $257.53M Low: $221.98M High: $282.06M avg. 6.99% |
Net Income
% change YoY
| $-17.91M N/A | $-61.59M -243.84% | $-25.09M 59.26% | Avg: $12.21M Low: $-121.81M High: $1.25B avg. 148.67% | Avg: $39.68M Low: $156.61M High: $2.40B avg. 224.89% | Avg: $281.90M Low: $231.31M High: $316.81M avg. 610.43% | Avg: $258.41M Low: $212.03M High: $290.41M avg. -8.33% |
EBITDA
% change YoY
| $-8.92M N/A | $-53.54M -499.75% | $-16.98M 68.28% | Avg: $-73.22M Low: $-79.43M High: $-63.88M avg. -331.22% | Avg: $-86.42M Low: $-94.65M High: $-74.49M avg. -18.02% | Avg: $-92.03M Low: $-100.80M High: $-79.33M avg. -6.49% | Avg: $-98.47M Low: $-107.85M High: $-84.87M avg. -6.99% |
EPS
% change YoY
| -$0.11 N/A | -$0.36 -227.27% | -$1.44 -300.00% | Avg: $1.64 Low: -$0.7 High: $7.2 avg. 214.03% | Avg: $3.92 Low: $0.9 High: $13.8 avg. 138.90% | Avg: $1.62 Low: $1.33 High: $1.82 avg. -58.70% | Avg: $1.49 Low: $1.22 High: $1.67 avg. -8.33% |
Operating Expenses
% change YoY
| $157.12M N/A | $172.72M 9.92% | $130.26M -24.58% | Avg: $169.25M Low: $147.65M High: $183.59M avg. 29.93% | Avg: $199.75M Low: $172.18M High: $218.78M avg. 18.02% | Avg: $212.73M Low: $183.36M High: $232.99M avg. 6.49% | Avg: $227.60M Low: $196.18M High: $249.28M avg. 6.99% |
FAQ
What is Rigel Pharmaceuticals stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 243.91% in 2025-2028.
We have gathered data from 4 analysts. Their low estimate is -121.81M, average is 12.21M and high is 1.25B.
What is Rigel Pharmaceuticals stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 23.83% in 2025-2028.
We have gathered data from 4 analysts. Their low revenue estimate is $167.07M, average is $191.50M and high is $207.73M.
What is Rigel Pharmaceuticals stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 71.47% in 2025-2028.
We have gathered data from 4 analysts. Their low earnings per share estimate is -$0.7, average is $1.64 and high is $7.2.
What is the best performing analyst?
In the last twelve months analysts have been covering Rigel Pharmaceuticals stock. The most successful analyst is Joseph Pantginis.